Ameritas Investment Partners, Inc. Avrobio, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.75 - $1.33 $2,046 - $3,629	-2,729 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$12.19 - $22.96 $12,385 - $23,327	1,016 Added 59.31%	2,729 $48,000
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $9,333 - $15,493	661 Added 62.83%	1,713 $24,000
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $7,265 - $15,009	550 Added 109.56%	1,052 $17,000
Q3 2018 Nov 13, 2018	BUY	$26.95 - $52.7 $13,528 - $26,455	502 New	502 $26,000

28.1M

100

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.